Vyacheslav E Semenov

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Molecules (Basel, Switzerland)

Molecular diversity

A.E. Arbuzov Institute of Organic and Physical Chemistry

This page only lists publications with an associated author ORCID identifier.

Affiliation History

A.E. Arbuzov Institute of Organic and Physical Chemistry

Russia

Head of laboratory :: Chemistry of nucleotide bases

Publications

Albina Y Ziganshina, Elina E Mansurova, Alexandra D Voloshina, Anna P Lyubina, Syumbelya K Amerhanova, Marina M Shulaeva, Irek R Nizameev, Marsil K Kadirov, Leysan R Bakhtiozina, Vyacheslav E Semenov, Igor S Antipin
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. Molecules (Basel, Switzerland) 28 (2) (2023)
Albina Y Ziganshina, Elina E Mansurova, Alexandra D Voloshina, Anna P Lyubina, Syumbelya K Amerhanova, Marina M Shulaeva, Irek R Nizameev, Marsil K Kadirov, Leysan R Bakhtiozina, Vyacheslav E Semenov, Igor S Antipin
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. Molecules (Basel, Switzerland) 28 (2) (2023)
Albina Y Ziganshina, Elina E Mansurova, Alexandra D Voloshina, Anna P Lyubina, Syumbelya K Amerhanova, Marina M Shulaeva, Irek R Nizameev, Marsil K Kadirov, Leysan R Bakhtiozina, Vyacheslav E Semenov, Igor S Antipin
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. Molecules (Basel, Switzerland) 28 (2) (2023)
Albina Y Ziganshina, Elina E Mansurova, Alexandra D Voloshina, Anna P Lyubina, Syumbelya K Amerhanova, Marina M Shulaeva, Irek R Nizameev, Marsil K Kadirov, Leysan R Bakhtiozina, Vyacheslav E Semenov, Igor S Antipin
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. Molecules (Basel, Switzerland) 28 (2) (2023)
Dmitry A Tatarinov, Bulat F Garifullin, Mayya G Belenok, Olga V Andreeva, Irina Yu Strobykina, Anna V Shepelina, Vladimir V Zarubaev, Alexander V Slita, Alexandrina S Volobueva, Liliya F Saifina, Marina M Shulaeva, Vyacheslav E Semenov, Vladimir E Kataev
The First 5'-Phosphorylated 1,2,3-Triazolyl Nucleoside Analogues with Uracil and Quinazoline-2,4-Dione Moieties: A Synthesis and Antiviral Evaluation. Molecules (Basel, Switzerland) 27 (19) (2022)
Vyacheslav E Semenov, Irina V Zueva, Sofya V Lushchekina, Eduard G Suleimanov, Liliya M Gubaidullina, Marina M Shulaeva, Oksana A Lenina, Konstantin A Petrov
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease. Molecules (Basel, Switzerland) 27 (22) (2022)
Olga V Andreeva, Bulat F Garifullin, Vladimir V Zarubaev, Alexander V Slita, Iana L Yesaulkova, Alexandrina S Volobueva, Mayya G Belenok, Maria A Man'kova, Liliya F Saifina, Marina M Shulaeva, Alexandra D Voloshina, Anna P Lyubina, Vyacheslav E Semenov, Vladimir E Kataev
Synthesis and Antiviral Evaluation of Nucleoside Analogues Bearing One Pyrimidine Moiety and Two D-Ribofuranosyl Residues. Molecules (Basel, Switzerland) 26 (12) (2021)
Vyacheslav E Semenov, Irina V Zueva, Marat A Mukhamedyarov, Sofya V Lushchekina, Elena O Petukhova, Lilya M Gubaidullina, Evgeniya S Krylova, Lilya F Saifina, Oksana A Lenina, Konstantin A Petrov
Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease. Molecules (Basel, Switzerland) 25 (18) (2020)
Olga V Andreeva, Bulat F Garifullin, Vladimir V Zarubaev, Alexander V Slita, Iana L Yesaulkova, Liliya F Saifina, Marina M Shulaeva, Maya G Belenok, Vyacheslav E Semenov, Vladimir E Kataev
Synthesis of 1,2,3-triazolyl nucleoside analogues and their antiviral activity. Molecular diversity 25 (1) (2020)

Vyacheslav E Semenov.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Vyacheslav E Semenov